Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

Recent infection doubles the risk of childhood stroke

New Monash University-led research has, for the first time in Australia, found that children with an infection in the past 60 days had roughly twice the risk of stroke. Published in Neurology, the study provides the first ...

Vaping: Emerging harms health systems can't ignore

When e-cigarettes first appeared around 2010, they were hailed as a breakthrough: nicotine delivery without the toxic tar and combustion byproducts of traditional cigarettes. Public health bodies cautiously endorsed them ...

Blood tests for cancer? We're still a way off

A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at once, catching disease ...

page 9 from 40